Skip Navigation


IJE Advance Access originally published online on September 10, 2007
International Journal of Epidemiology 2007 36(5):969-976; doi:10.1093/ije/dym073
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
36/5/969    most recent
dym073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by McGowan, C. C
Right arrow Articles by Masys, D. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGowan, C. C
Right arrow Articles by Masys, D. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2007; all rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme

Catherine C McGowan1,*, Pedro Cahn2, Eduardo Gotuzzo3, Denis Padgett4, Jean W Pape5, Marcelo Wolff6, Mauro Schechter7 and Daniel R Masys1

1Vanderbilt University School of Medicine, Nashville, TN, USA.
2Fundación Huésped and Hospital Fernández, Buenos Aires, Argentina.
3Universidad Peruana Cayetano Heredia Facultad de Medicina and Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
4Instituto Hondureño de Seguridad Social and Universidad Autonoma de Honduras, Tegucigalpa, Honduras.
5Les Centres GHESKIO, Port-au-Prince, Haiti.
6Fundación Arriarán and Facultad de Medicina, Universidad de Chile, Santiago, Chile.
7Projeto Praça Onze, Hospital Universitário Clementino Fraga Filho and Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

* Corresponding author. Division of Infectious Diseases, Vanderbilt University School of Medicine, 345 24th Avenue North, Suite 103, Nashville, TN 37203, USA. E-mail: c.mcgowan@vanderbilt.edu

Accepted 20 March 2007

The first 150 words of the full text of this article appear below.


    How did the study come about?
 
The HIV/AIDS epidemic has evolved in its third decade to be an unprecedented human catastrophe of global scale and importance. Although an historic response for change and intervention has led to decreased rates of new infections and HIV-associated mortality in many communities, the enormity of the pandemic continues to overwhelm already constrained resources everywhere. Improved understanding of antiretroviral therapy (ART) responses and viral and host characteristics, both within and between diverse settings and populations, is needed to guide initiatives in HIV prevention and treatment worldwide.

The merging of existing clinical and research data related to HIV infection and its associated disorders answers questions that currently cannot be addressed using randomized trials or single sources of data. Cohorts such as MACS,1 WIHS,2 HIVRN,3 EuroSida and the Swiss HIV Cohort4–6 have produced important observations regarding the epidemiology and long-term outcomes of HIV-infected individuals residing in North America and Europe, both before and . . . [Full Text of this Article]


    The IeDEA initiative
 

    CCASAnet core aims, organization and scientific agenda
 

    What does it cover and who is in the sample?
 

    How often have patients been followed-up and what is measured?
 

    What is the attrition rate likely to be?
 

    What protection of human subjects is used?
 

    What are the main strengths and weaknesses of CCASAnet?
 

    How can I collaborate? Where can I find out more?
 

    Supplementary material
 

    Appendix
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?